Skip to main content
FinSpry Logo
FinSpry
RGEN logo
RGEN
(NASDAQ)
Repligen Corporation
$137.60-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Repligen (RGEN) Stock Price & Financial Analysis

Repligen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$132.28 - $148.37
52-Week High$175.77
52-Week Low$100.99
Open$144.23
Volume2.74M
Average Volume (3M)1.15M
Market Cap7.80B
Shares Outstanding56.67M
P/E Ratio (TTM)151.71
Price to Sales (P/S)10.21
Price to Book (P/B)3.70
EV/EBITDA45.80
Revenue (TTM)763.34M
Net Income (TTM)51.40M
Free Cash Flow (TTM)104.11M
EPS (TTM)$0.91
Profit Margin6.73%
Operating Margin8.27%
Return on Equity (ROE)2.44%
Debt to Equity0.33
50-Day MA$129.78
200-Day MA$140.04
52-Week Change17.48%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Repligen

What is the current stock price for RGEN?

As of the latest trading session, RGEN stock trades at $137.60. The 52-week range is $100.99–$175.77, with a day range of $132.28–$148.37.

What is the P/E ratio for RGEN?

Repligen's trailing P/E ratio is 151.7, meaning investors pay $151.7 for every $1 of annual earnings. Repligen operates in the Healthcare sector.

Does RGEN pay dividends?

Repligen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RGEN?

Based on 14 analysts, the consensus for RGEN is Buy.

What is the market cap of RGEN?

Repligen's market capitalization is $7.80B, classifying it as a mid-cap company. Repligen operates in the Healthcare sector within the Medical Instruments & Supplies industry.